Method for preparing amifostine microspheres

A technology of amifostine and microspheres, which is applied in the directions of non-active ingredient medical preparations, medical preparations containing active ingredients, and pharmaceutical formulas, etc., can solve the problems of short action time and the like

Inactive Publication Date: 2010-02-03
NORTHWESTERN POLYTECHNICAL UNIV
View PDF2 Cites 15 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] In order to overcome the problem of short drug action time of amifostine freeze-dried powder in the prior art, the present invention provides a preparation meth

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0021] Example 1: Take 100 mg of a biodegradable polymer polylactic acid-polyglycolic acid copolymer with a molar ratio of 75:25 and a molecular weight of 50,000, and dissolve it in 3 ml of a methylene chloride solution containing 0.1% lecithin to form an oil phase O ,Add the first water phase W to this oil phase 1 , 0.4ml of amifostine aqueous solution with a concentration of 50mg / ml, emulsify with a phacoemulsifier to obtain W 1 / O emulsion, and then add the obtained emulsion to the second water phase W 2 , 2% polyvinyl alcohol aqueous solution, the ultrasonic emulsifier is again emulsified to obtain W 1 / O / W 2 After the emulsion is formed, magnetic stirring is carried out under ice bath conditions at a stirring speed of 1000 rpm. After stirring and volatilizing for 6 hours, the microspheres are collected by centrifugation at 4°C for 30 min at 6000 rpm and washed with 10 ml of distilled water for 4 times. After pre-freezing, Freeze-drying at -50℃ for 24h. The embedding rate of...

Example Embodiment

[0022] Example 2: Take 100 mg of a biodegradable polymer polylactic acid-polyglycolic acid copolymer with a molar ratio of 75:25 and a molecular weight of 15000, and dissolve it in 3 ml of a methylene chloride solution containing 0.1% lecithin to form an oil phase O. Add the first water phase W 1 , 0.4ml concentration of 50mg / ml amifostine aqueous solution, phacoemulsifier for emulsification, get W 1 / O emulsion, the obtained emulsion is added to the second water phase W 2 , 2% polyvinyl alcohol aqueous solution, the ultrasonic emulsifier is again emulsified to obtain W 1 / O / W 2 After the emulsion is formed, magnetic stirring is carried out under ice bath conditions at a stirring speed of 1000 rpm. After stirring and volatilizing for 6 hours, the microspheres are collected by centrifugation at 4°C for 30 min at 6000 rpm and washed with 10 ml of distilled water for 4 times. After pre-freezing, Freeze-drying at -50℃ for 24h. The embedding rate of the obtained microspheres is 20%, ...

Example Embodiment

[0023] Example 3: The preparation method is the same as that of Example 1, wherein the biodegradable polymer is a polylactic acid-polyglycolic acid copolymer with a molar ratio of 50:50 and a molecular weight of 15000. After testing, the embedding rate of the microspheres is 25%. The spherical particle size is 400-800nm, the cumulative release in 24h is 68%-80%, and the drug release in vitro can reach 80h.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Particle sizeaaaaaaaaaa
Particle sizeaaaaaaaaaa
Particle sizeaaaaaaaaaa
Login to view more

Abstract

The invention discloses a method for preparing amifostine microspheres, comprising the following steps: adopting an emulsification-solvent evaporation method to dissolve biodegradable polymers into organic solvents, adding surfactant, mixing with amifostine aqueous solution, emulsifying the mixture by an ultrasonic emulsifier, dispersing emulsion into polyvinyl alcohol aqueous solution to undergofurther ultrasonic emulsification to form w/o/w type emulsion, carrying out magnetic stirring on the w/o/w type emulsion under low temperature to volatilize the organic solvents, then carrying out centrifuging, washing and freeze drying to obtain the amifostine microspheres. By using the method of the invention, the organic solvent is low in usage amount, the preparation time is short, the grain sizes of the microspheres are controlled between 400nm and 900nm and the in-vitro release time of the microspheres lasts as long as 75-100h.

Description

technical field [0001] The invention relates to a preparation method of microspheres, in particular to a preparation method of amifostine microspheres. Background technique [0002] Amifostine (WR-2721, amifostine) was approved by the US FDA in 1999 for anti-nephrotoxicity of chemotherapy drugs and for reducing xerostomia caused by radiotherapy in tumor patients. It is also a good radiation protection and cell protection agent. There are significant effects in the injury of tumor chemotherapy, but there are inherent deficiencies in its clinical use. Firstly, the plasma clearing speed is very fast, less than 10% of the drug remains in the blood 6 minutes after intravenous injection, and the drug has a short duration of action; secondly, oral administration is ineffective and has side effects such as nausea, vomiting, and acute hypotension. [0003] The document "Chinese Patent Publication No. CN1291475" discloses a freeze-dried amifostine powder preparation and its preparati...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/16A61K31/661A61K47/34A61K47/36A61K47/42A61P1/02A61P39/00
Inventor 卢婷利孙伟光于洋陈涛
Owner NORTHWESTERN POLYTECHNICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products